Healthcare IPO delivers modest gains as Gujarat Kidney debuts positively

Gujarat Kidney and Super Speciality made a steady start on the stock exchanges, listing at around a 6 percent premium over its IPO price in a relatively calm market environment. The stock debuted on the NSE at higher than issue levels, reflecting measured investor confidence rather than speculative exuberance. The listing performance came despite mixed broader market cues, indicating selective interest in healthcare focused businesses.